arsenic has been researched along with Endometrial Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gou, Y; Liu, J; Liu, Z; Qin, Y; Wang, H; Wu, JZ; Xu, Y | 1 |
| Bae-Jump, VL; Boggess, JF; Gehrig, PA; Zhou, C | 1 |
| Bae-Jump, V; Boggess, JF; Gehrig, PA; Zhou, C | 1 |
3 other study(ies) available for arsenic and Endometrial Neoplasms
| Article | Year |
|---|---|
Apoptosis and necrosis induced by novel realgar quantum dots in human endometrial cancer cells via endoplasmic reticulum stress signaling pathway.
Topics: Apoptosis; Arsenicals; Cell Line, Tumor; Endometrial Neoplasms; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Female; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Humans; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Necrosis; Quantum Dots; RNA, Messenger; Signal Transduction; Sulfides; Transcription Factor CHOP | 2015 |
Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells.
Topics: Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Endometrial Neoplasms; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Oxides | 2008 |
Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Growth Processes; Cell Line, Tumor; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Flow Cytometry; Humans; Oxides; RNA, Messenger; Telomerase | 2007 |